Weak contractility (BCI < 100) 5) Straining to void 6) Poorly sustained detrusor contraction 7) Uncoordinated EMG activity and 8) Intermittent flow.
INTRODUCTION AND OBJECTIVES:
Renal transplant is the most desired and cost-effective therapy for patients with end stage renal disease. While a lower urinary tract cause of end-stage renal disease is not an absolute contraindication to renal transplantation, appropriate vesical storage and drainage is imperative for survival and function of the graft. Thus, careful identification of certain transplant patients for preoperative urodynamics (UDS) may prevent post-transplant urological complications and possible graft failure.
METHODS: We retrospectively reviewed all patients who underwent a renal transplantation with subsequent UDS testing at our institution between January 2000 to October 2016. None of the patients had preoperative UDS. Twenty-eight patients were identified and 11 were excluded due to missing data. Information collected included demographics, past medical and surgical history, transplant indication, dialysis duration, pre-transplant urine output, reason for urological evaluation, and UDS results. Characteristics of these patients were analyzed to assess for trends that may predict post-transplant urological issues and graft compromise based on pre-transplant risk factors.
RESULTS: The most common comorbidities in the cohort were hypertension (88%), diabetes mellitus (53%), coronary artery disease (41%). The most common indications for transplantation were diabetes mellitus (47%) followed by hypertension (41%). Six of the 17 patients (35%) had post-transplant urological issues resulting in potential compromise of their grafts. In order, the most common reasons for post-transplant urological evaluation in these six patients were urinary retention/incomplete emptying, recurrent urinary tract infections, elevated creatinine, and transplant hydronephrosis. Urodynamic findings in these patients revealed incomplete emptying or retention (67%), detrusor overactivity (67%), hypotonic bladder (33%), atonic bladder (33%), poor compliance (33%), and small capacity (33%).
CONCLUSIONS: Our findings suggest urological evaluation with urodynamic testing is underutilized in the diagnosis, treatment and optimization of pre-existing urological conditions in order to improve graft success and avoid unforeseen problems in the pre-transplant setting. Currently, there is no consensus in existing guidelines regarding which patients should have formal urological evaluation with urodynamics before undergoing transplantation. Additional efforts in this area is necessary to improve the overall success of renal transplantations.
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MP56-04 URODYNAMIC FINDINGS IN PATIENTS WITH NOCTURIA: AN AGE-AND GENDER-MATCHED STUDY
Elisabeth M. Sebesta*, Joseph M. Caputo, Dina Manasherova, Carrie M. Aisen, Doreen E. Chung, New York, NY INTRODUCTION AND OBJECTIVES: Nocturia, waking !1 time to void during sleep with each void preceded by sleep, negatively impacts quality of life. Nocturia patients are a heterogeneous cohort due to its multifactorial causes, both urologic and systemic. Urodynamic (UDS) findings in patients with nocturia are not well described and may help guide management options. Our objective was to compare UDS findings in patients with and without nocturia.
METHODS: We retrospectively reviewed UDS of 1124 patients (2010-2017), of whom 484 (43%) presented with nocturia. Agematching of patients with and without nocturia was done, separated by gender (156 men, 596 women). Presenting symptoms, demographics, and UDS findings were compared between patients with and without nocturia.
RESULTS: In both genders, past medical history including diabetes and cardiovascular disease did not differ between groups. However female patients with nocturia had significantly lower body mass index (BMI) (P[0.003) (TABLE). Men and women with nocturia were more likely to have daytime symptoms including frequency, urgency, and urgency incontinence (UUI). UDS findings in men did not differ between the cohorts, including findings of bladder outlet obstruction (BOO) and detrusor overactivity (DO). However, women with nocturia were more likely to have BOO (P[0.025). Men were further stratified by degree of nocturia in 27/76 (36%) patients. 37% reported 1-2 episodes per night and 63% 3 or more. When comparing to an age-matched cohort without nocturia, patients with 1-2 episodes had larger bladder capacity (602AE386mL vs. 356AE213mL, P[0.10), and significantly higher post-void residual (PVR) (322AE275mL vs. 102AE185mL, P[0.05) and incomplete emptying (P[0.005).
CONCLUSIONS: Here we present a unique study which compares UDS findings in contemporary, age-and gender-matched cohorts of patients with and without nocturia. While treatment of nocturia often attempts at resolving DO or BOO, our study suggests these findings are not necessarily present more often with nocturia. Women with nocturia were more likely to have BOO while men with mild nocturia were more likely to have larger bladder capacity, higher PVR, and incomplete emptying, suggesting an association between nocturia and longstanding BOO. This study highlights the multifactorial etiology of nocturia and its related management challenge.
